Andrew Frisch is a PhD student in the Program in Microbiology and Immunology at the University of Pittsburgh. In 2011 Andrew received his BS in Biology from Temple University in Philadelphia. From then until 2018, he developed many research interests while working at the University of Pennsylvania. Most recently before joining the lab, he spent time working in the laboratory of Dr. Carl June developing various engineering strategies for the development of chimeric antigen receptor (CAR) T cells. It was during this time that he discovered his interest in cancer immunotherapy. Andrew joined the lab in April of 2019.
With his research, Andrew aims to improve adoptive cell therapy for the treatment of cancer. He is specifically focused on the manipulation of T cell metabolism to improve survival and anti-tumor efficacy of adoptively transferred T cells in the tumor microenvironment.
What is your favorite piece of lab equipment? Seahorse (can it be my least favorite too?)
What immune cell are you? Macrophage (if I could be a professional eater...)
Go-to karaoke song? Beast of Burden by The Rolling Stones
Favorite sandwich? Italian roast pork with broccoli rabe and sharp provolone (the REAL philly star sandwich)